Clinical Trials Browser

Advanced Cancer × Dasatinib × Clear all

NCT02750514 2021-03-22

FRACTION-Lung

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer

NCT00895128 2015-07-13

Study of Erlotinib in Combination With Dasatinib

Phase 1 Completed

Advanced Cancer